{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T16:59:16Z","timestamp":1783875556422,"version":"3.55.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T00:00:00Z","timestamp":1331856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033392","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T21:19:36Z","timestamp":1331932776000},"page":"e33392","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China"],"prefix":"10.1371","volume":"7","author":[{"given":"Qiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.","volume":"335","author":"Q Fang","year":"2005","journal-title":"Virology"},{"key":"ref2","first-page":"215","article-title":"DNA sequence analysis of the Hind III M fragment from Chinese vaccine strain of vaccinia virus.","volume":"4","author":"VJ Liu","year":"1989","journal-title":"Proc Chin Acad Med Sci Peking Union Med Coll"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1099\/0022-1317-66-8-1819","article-title":"Variation in the HindIII restriction fragments of DNA from the Chinese Tian Tan strain of vaccinia virus.","volume":"8)","author":"YT Hou","year":"1985","journal-title":"J Gen Virol 66 (Pt"},{"key":"ref4","article-title":"Smallpox and Its Eradication.","author":"FADA Fenner","year":"1988"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1743-422X-8-302","article-title":"Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.","volume":"8","author":"L Zhao","year":"2011","journal-title":"Virol J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2008.06.011","article-title":"Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.","volume":"26","author":"K Dai","year":"2008","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/BF01718609","article-title":"Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.","volume":"141","author":"JH Zhu","year":"1996","journal-title":"Arch Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jmv.21667","article-title":"The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice.","volume":"82","author":"H Liu","year":"2010","journal-title":"J Med Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1016\/j.vaccine.2009.09.033","article-title":"Poxvirus-vectored vaccines for rabies--a review.","volume":"27","author":"J Weyer","year":"2009","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.vaccine.2009.02.006","article-title":"Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.","volume":"27","author":"CS Kyriakis","year":"2009","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1016\/j.vaccine.2007.01.118","article-title":"Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines.","volume":"25","author":"Y Wan","year":"2007","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination.","volume":"9","author":"E Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0264-410X(93)90079-D","article-title":"Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination.","volume":"11","author":"TM Kundig","year":"1993","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein.","volume":"337","author":"EL Cooney","year":"1991","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0092-1157(87)80013-6","article-title":"The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers.","volume":"15","author":"JB Katz","year":"1987","journal-title":"J Biol Stand"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox.","volume":"21","author":"TM Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2005.05.027","article-title":"Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.","volume":"130","author":"O Eyal","year":"2005","journal-title":"J Virol Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CDLI.11.2.406-410.2004","article-title":"Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.","volume":"11","author":"A Cosma","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia-neutralization assay based on reporter-gene expression.","volume":"188","author":"J Manischewitz","year":"2003","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JCM.41.11.5046-5052.2003","article-title":"Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.","volume":"41","author":"MC Sprangers","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2144\/97236pf01","article-title":"Quantification of gene expression with a secreted alkaline phosphatase reporter system.","volume":"23","author":"TT Yang","year":"1997","journal-title":"Biotechniques"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1128\/JVI.75.3.1516-1521.2001","article-title":"Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking: population analysis of adenovirus capsid association with cells is predictive of adenovirus infectivity.","volume":"75","author":"T Vincent","year":"2001","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.","volume":"12","author":"S Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.","volume":"70","author":"N Mittereder","year":"1996","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus.","volume":"220","author":"Y Ichihashi","year":"1996","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.2047875","article-title":"Vaccinia virus: a tool for research and vaccine development.","volume":"252","author":"B Moss","year":"1991","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.93.21.11349","article-title":"Applications of pox virus vectors to vaccination: an update.","volume":"93","author":"E Paoletti","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","article-title":"Vaccinia virus: a selectable eukaryotic cloning and expression vector.","volume":"79","author":"M Mackett","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.","volume":"84","author":"S Brandler","year":"2010","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/nar\/20.2.195","article-title":"Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.","volume":"20","author":"R Bartenschlager","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.","volume":"79","author":"Y Ami","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/0-306-46817-4_34","article-title":"Intralesional vaccinia\/GM-CSF recombinant virus in the treatment of metastatic melanoma.","volume":"465","author":"MJ Mastrangelo","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ymthe.2004.10.015","article-title":"Fighting cancer with vaccinia virus: teaching new tricks to an old dog.","volume":"11","author":"Y Shen","year":"2005","journal-title":"Mol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.90.5.1882","article-title":"Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.","volume":"90","author":"EL Cooney","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination.","volume":"171","author":"S Crotty","year":"2003","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study.","volume":"121","author":"DD Taub","year":"2008","journal-title":"Am J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","article-title":"Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.","volume":"76","author":"LE Harrington","year":"2002","journal-title":"J Virol"},{"key":"ref38","article-title":"SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.","author":"L Lai","year":"2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination.","volume":"211","author":"IJ Amanna","year":"2006","journal-title":"Immunol Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00018-006-6313-2","article-title":"Keeping the memory of smallpox virus.","volume":"63","author":"B Puissant","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.294.5544.985","article-title":"Bioterrorism. Smallpox vaccinations: how much protection remains?","volume":"294","author":"J Cohen","year":"2001","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.","volume":"281","author":"DA Henderson","year":"1999","journal-title":"Jama"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/aje\/kwg225","article-title":"Analysis of historical data suggests long-lasting protective effects of smallpox vaccination.","volume":"158","author":"M Eichner","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref44","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox.","volume":"52","author":"JK Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection.","volume":"80","author":"G Chaudhri","year":"2006","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.","volume":"46","author":"J Neff","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(80)90485-7","article-title":"Expression of the vaccinia virus genome: analysis and mapping of mRNAs encoded within the inverted terminal repetition.","volume":"21","author":"R Wittek","year":"1980","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2007.03.012","article-title":"The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes.","volume":"144","author":"W Zhu","year":"2007","journal-title":"J Virol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T09:34:25Z","timestamp":1593855265000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033392"}},"subtitle":[],"editor":[{"given":"Erika Martins","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,16]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033392","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,16]]}}}